Perlara Partners with Notre Dame to Develop Therapies for Pompe, Cori Diseases
Perlara biotech is collaborating with the University of Notre Dame in Indiana and the Warren Family Research Center for Drug Discovery and Development to develop new treatments for glycogen storage disorders, including Pompe and Cori diseases. Pompe disease mainly causes muscle weakness, impaired gait, and muscle pain. The three types…